Table 1 Patient demographic and baseline characteristics
Characteristic | FAS population N = 514 | FAS-targeted population at Months 0 and 24 N = 264 |
|---|---|---|
Age, years | 79.6 (7.9) | 79.2 (7.7) |
Female, n (%) | 315 (61.3) | 163 (61.7) |
Study eye, n (%) | ||
Right | 281 (54.7) | 149 (56.4) |
Left | 233 (45.3) | 115 (43.6) |
Duration of nAMD, months | 1.4 (8.7) | 1.8 (11.0) |
BCVA (letters) score at month 0 | 56.3 (18.6) | 57.3 (17.9) |
BCVA (letters) categories, n (%) | ||
< 50 | 143 (27.8) | 65 (24.6) |
50–55 | 64 (12.5) | 35 (13.3) |
55–70 | 151 (29.4) | 78 (29.5) |
≥ 70 | 156 (30.4) | 86 (32.6) |
Intraocular pressure, mm Hg (n = 262) | 14.9 (3.1) | – |
Diabetes, n (%) | 43 (8.4) | – |
Hypertension, n (%) | 196 (38.1) | – |
Cardiovascular diseases, n (%) | 87 (16.9) | – |